Current Status of Bicarbonate in CKD
- 1 March 2015
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 26 (3), 515-523
- https://doi.org/10.1681/asn.2014020205
Abstract
Metabolic acidosis was one of the earliest complications to be recognized and explained pathologically in patients with CKD. Despite the accumulated evidence of, deleterious effects of acidosis, treatment of acidosis has been tested very little, especially with respect to standard clinical outcomes. On the basis of fundamental research and small alkali supplementation trials, correcting metabolic acidosis has a strikingly broad array of potential benefits. This review summarizes the published evidence on the association between serum bicarbonate and clinical outcomes. We discuss the role of alkali supplementation in CKD as it relates to retarding kidney disease progression, improving metabolic and musculoskeletal complications.Keywords
This publication has 95 references indexed in Scilit:
- Association of Serum Bicarbonate With Risk of Renal and Cardiovascular Outcomes in CKD: A Report From the Chronic Renal Insufficiency Cohort (CRIC) StudyAmerican Journal of Kidney Diseases, 2013
- Net endogenous acid production is associated with a faster decline in GFR in African AmericansKidney International, 2012
- Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adultsKidney International, 2012
- Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connectionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac PathwayPLOS ONE, 2011
- Bicarbonate Supplementation Slows Progression of CKD and Improves Nutritional StatusJournal of the American Society of Nephrology, 2009
- IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle WastingJournal of the American Society of Nephrology, 2009
- Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKDNephrology Dialysis Transplantation, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004